Response Biomedical Corp. Announces Intention to Enter Into Private Placement - Seite 2

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the Company. Examples of forward-looking statements in this press release include statements regarding our ability to successfully complete the Private Placement, and amount of proceeds raised in the Private Placement and the intended use of the net proceeds of the Private Placement. These statements are only predictions based on the Company's current expectations and projections about future events. Although the Company believes the expectations reflected in such forward-looking statements, and the assumptions upon which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct and if such expectations are not met, our business may suffer.

Readers should not place undue reliance on these statements. Actual events or results may differ materially. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Many factors may cause the Company's actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and other filings with the Securities and Exchange Commission and Canadian securities regulatory authorities. As stated in our Management's Discussion and Analysis of Financial Condition and Results of Operations filed on EDGAR (as Item 2 of our Quarterly Report on Form 10-Q) and SEDAR on May 16, 2016, without additional financing, our current cash may not be sufficient to allow us to continue as a going concern beyond the second quarter of 2016. Due to our history of losses and recent significant decreases in China product sales, if additional financing is not obtained and we do not achieve profitable operations, the outcomes of which cannot be predicted at this time, there is substantial doubt over our ability to continue as a going concern.